Skip to main content
. 2018 Jun 28;5(3):ENEURO.0164-18.2018. doi: 10.1523/ENEURO.0164-18.2018

Table 4.

Effects of MTEP (mGluR5 antagonist) on response latencies

Response latency Dose Mean (ms) SE N
Sample phase
F(3,18) = 1.149, p = 0.356
Vehicle 1729.74 103.44 7
0.1 µg 2213.25 388.26 7
0.3 µg 2422.28 305.92 7
1.0 µg 1893.21 224.53 7
Matching phase
F(3,18) = 2.55, p = 0.088
Vehicle 1013.31 82.56 7
0.1 µg 1014.81 90.96 7
0.3 µg 1017.94 66.11 7
1.0 µg 942.91 91.39 7